A5102724002- Microscopic Colitis
- Inflammatory Bowel Disease
- Viral Infections and Immunology Research
- Cardiac, Anesthesia and Surgical Outcomes
- Potassium and Related Disorders
- Bariatric Surgery and Outcomes
- Diagnosis and treatment of tuberculosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Celiac Disease Research and Management
- Diabetes Treatment and Management
- Acute Lymphoblastic Leukemia research
- Gastrointestinal motility and disorders
- Gastric Cancer Management and Outcomes
- Esophageal and GI Pathology
- Health Systems, Economic Evaluations, Quality of Life
- Biosimilars and Bioanalytical Methods
- Immunodeficiency and Autoimmune Disorders
University Hospital Complex Of Vigo
2010-2023
Servicio Gallego de Salud
2023
Banner - University Medical Center Tucson
2023
University of Arizona
2023
National Institute of Cardiovascular Diseases
2016
Complexo Hospitalario Universitario A Coruña
2016
Kitasato Institute Hospital
2016
Kitasato University
2016
The aims of this study were to assess the risk relapse after discontinuation anti-tumor necrosis factor (anti-TNF) drugs in patients with inflammatory bowel disease (IBD), identify factors associated relapse, and evaluate overcome retreatment same anti-TNF those who relapsed.This was a retrospective, observational, multicenter study. IBD had been treated anti-TNFs whom these discontinued clinical remission achieved included.A total 1,055 included. incidence rate 19% 17% per patient-year...
Abstract Background Background: The feasibility of anti-TNF discontinuation in inflammatory bowel disease (IBD) must be proven clinical trials including patients clinical, endoscopic, and radiologic remission at the time withdrawal to make recommendations for practice. Aims Primary: compare rates 1 year who discontinue treatment vs. those continue treatment. Secondary objectives: know effect on relapse-free time, mucosal healing safety; identify predictive factors relapse. Methods...
Introduction Methotrexate (MTX) has been utilized for the treatment of Crohn’s disease (CD) decades. Nevertheless, current data provide equivocal evidence on efficacy MTX in CD. The aims this study were to describe maintenance remission CD and identify factors associated with probability steroid-free clinical a multicenter European referral center cohort. Patients methods This was retrospective cohort analysis. Consecutive patients treated included from 11 centers. receiving concomitant...
Background: CT-P13 is the first approved infliximab (IFX) biosimilar.It has proven equivalent to IFX treatment in several rheumatoid disorders; however, limited data are available on its efficacy for use inflammatory bowel disease (IBD) patients.We evaluated clinical from our year, using assess and safety IBD patients.Methods: This retrospective cohort study included all consecutive Crohn's (CD) or ulcerative colitis (UC) patients treated between March 2014 April 2015.Clinical remission was...
<b>Introduction:</b> Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airway obstruction. Patients with COPD are more likely to develop endothelial dysfunction(ED). ED the interruption of homeostasis, release inflammatory cytokines and increased vasoactive substance production. <b>Objective:</b> To evaluate relationship between GOLD stage in patients COPD. <b>Materials methods:</b> Transversal study (n=42), 18 years or older. was evaluated photoplethysmography, a...
dysbiosis, including loss of species diversity amongst Bacteroidetes.Fresh FMT following AFM pretreatment contributed to the improvement intestinal dysbiosis in patients with UC via transplantation living Bacteroidetes cells from donors.Suppression indigenous bacteria system commensal colonisation factor or antagonistic abilities by before may have promoted new entry derived donors FMT, thereby improving bacterial composition microbiota at 4 weeks after fresh FMT.Conclusions: To best our...
Abstract Background Oral corticosteroids remain as the first-line treatment for moderately active ulcerative colitis (UC). In controlled studies, they achieved clinical remission in 30-60% of patients at 30 days. severe systemic diseases, intravenous bolus administration methyl-prednisolone accelerates response and increases therapeutic efficacy corticosteroids. Aims To assess additive effect IV boluses an outpatient Schedule on rate UC. Methods Randomized, controlled, open study. Inclusion...
Nowadays chromoendoscopy is considered the gold standard to detect colonic displasia in patients with inflammatory bowel diseases (IBD). Active endoscopical lesions impair detection at chromoendoscopy, leading repeat this exploration after healing and increasing cost of these endoscopic surveillance programs. Fecal calprotectin values have claimed accurately identify without as appropriate candidates for performing a but cut-off not been standardised yet. Consecutive IBD scheduled clinically...